Rare diseases
Investigational molecules
Locations
54 Rue Henri Sainte Claire Deville, Cs 91400, 83056 Toulon, France
Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer in Toulon, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Cardiac failure, Non-small cell lung cancer stage IV, Non-small cell lung cancer metastatic, and other specialisations. This site conducts important research.
The medical center is at the forefront of oncology research, focusing on innovative treatments for various types of cancer, including Non-Small Cell Lung Cancer (NSCLC) and breast carcinoma. The center's research aims to improve survival rates and quality of life for cancer patients through cutting-edge therapies.
By exploring novel combinations of immunotherapy and chemotherapy, the center is paving the way for more effective cancer treatments.
Specializing in cardiology, the center conducts research on heart failure and septic cardiomyopathy. The focus is on developing therapies that enhance cardiac function and reduce the risk of adverse cardiovascular events.
Through innovative clinical trials, the center is advancing the understanding of heart diseases and improving patient outcomes.
The center is renowned for its research in gastroenterology, particularly in the management of inflammatory bowel diseases such as Crohn's Disease and Ulcerative Colitis. The research focuses on optimizing treatment strategies to achieve better disease control.
By integrating patient education and telemonitoring, the center is enhancing the management of these chronic conditions.
In the field of hematology, the center is dedicated to improving treatments for blood disorders, including Chronic Lymphocytic Leukemia (CLL). The research aims to develop therapies that target specific genetic mutations to improve patient outcomes.
Through rigorous clinical trials, the center is contributing to the development of personalized medicine approaches in hematology.
The center's neurology research focuses on neonatal conditions such as hypoxic-ischaemic encephalopathy. The goal is to explore regenerative therapies that can improve neurological outcomes in affected infants.
By investigating the use of stem cell therapies, the center is at the cutting edge of neonatal neurological research.
Research in thrombosis and hemostasis at the center is focused on improving the management of conditions like venous thromboembolism and deep vein thrombosis. The center is exploring new anticoagulant therapies to enhance patient safety and efficacy.
Through comprehensive clinical trials, the center is advancing the treatment protocols for thrombotic disorders.
Clinical trials currently enrolling participants at this site.
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
FranceStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
FranceStudy of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function
FranceStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
FranceStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
FranceStudy of dexmedetomidine and a drug combination for treating patients on mechanical ventilation with septic shock.
FranceStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
FranceOne-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease
FranceAnti‑PD1 Therapy with pembrolizumab and cemiplimab in first‑line advanced non‑small cell lung cancer patients with high PD‑L1 expression
FranceA study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy
FranceStudy of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer
FranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
